These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1091 related items for PubMed ID: 32781391

  • 1. Biochanin-A ameliorates pulmonary fibrosis by suppressing the TGF-β mediated EMT, myofibroblasts differentiation and collagen deposition in in vitro and in vivo systems.
    Andugulapati SB, Gourishetti K, Tirunavalli SK, Shaikh TB, Sistla R.
    Phytomedicine; 2020 Nov; 78():153298. PubMed ID: 32781391
    [Abstract] [Full Text] [Related]

  • 2. Andrographolide ameliorates bleomycin-induced pulmonary fibrosis by suppressing cell proliferation and myofibroblast differentiation of fibroblasts via the TGF-β1-mediated Smad-dependent and -independent pathways.
    Li J, Feng M, Sun R, Li Z, Hu L, Peng G, Xu X, Wang W, Cui F, Yue W, He J, Liu J.
    Toxicol Lett; 2020 Mar 15; 321():103-113. PubMed ID: 31706003
    [Abstract] [Full Text] [Related]

  • 3. Sulforaphane attenuates pulmonary fibrosis by inhibiting the epithelial-mesenchymal transition.
    Kyung SY, Kim DY, Yoon JY, Son ES, Kim YJ, Park JW, Jeong SH.
    BMC Pharmacol Toxicol; 2018 Apr 02; 19(1):13. PubMed ID: 29609658
    [Abstract] [Full Text] [Related]

  • 4. Tanshinone IIA ameliorates bleomycin-induced pulmonary fibrosis and inhibits transforming growth factor-beta-β-dependent epithelial to mesenchymal transition.
    Tang H, He H, Ji H, Gao L, Mao J, Liu J, Lin H, Wu T.
    J Surg Res; 2015 Jul 02; 197(1):167-75. PubMed ID: 25911951
    [Abstract] [Full Text] [Related]

  • 5. Reversion of in vivo fibrogenesis by novel chromone scaffolds.
    Kim HS, Yoon YM, Meang MK, Park YE, Lee JY, Lee TH, Lee JE, Kim IH, Youn BS.
    EBioMedicine; 2019 Jan 02; 39():484-496. PubMed ID: 30611717
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Geneticin ameliorates pulmonary fibrosis by attenuating the TGF-β/Smad via modulating AMPK/SIRT1 signaling.
    Tirunavalli SK, Andugulapati SB.
    Life Sci; 2024 Jun 01; 346():122626. PubMed ID: 38614295
    [Abstract] [Full Text] [Related]

  • 8. Paeoniflorin suppresses TGF-β mediated epithelial-mesenchymal transition in pulmonary fibrosis through a Smad-dependent pathway.
    Ji Y, Dou YN, Zhao QW, Zhang JZ, Yang Y, Wang T, Xia YF, Dai Y, Wei ZF.
    Acta Pharmacol Sin; 2016 Jun 01; 37(6):794-804. PubMed ID: 27133302
    [Abstract] [Full Text] [Related]

  • 9. Arsenic trioxide inhibits transforming growth factor-β1-induced fibroblast to myofibroblast differentiation in vitro and bleomycin induced lung fibrosis in vivo.
    Luo F, Zhuang Y, Sides MD, Sanchez CG, Shan B, White ES, Lasky JA.
    Respir Res; 2014 Apr 24; 15(1):51. PubMed ID: 24762191
    [Abstract] [Full Text] [Related]

  • 10. Emodin alleviates bleomycin-induced pulmonary fibrosis in rats.
    Guan R, Zhao X, Wang X, Song N, Guo Y, Yan X, Jiang L, Cheng W, Shen L.
    Toxicol Lett; 2016 Nov 16; 262():161-172. PubMed ID: 27717887
    [Abstract] [Full Text] [Related]

  • 11. USP7 Promotes TGF-β1 Signaling by De-Ubiquitinating Smad2/Smad3 in Pulmonary Fibrosis.
    Tang F, Gong H, Ke T, Yang W, Yang Y, Liu Z.
    Discov Med; 2024 Aug 16; 36(187):1616-1626. PubMed ID: 39190377
    [Abstract] [Full Text] [Related]

  • 12. Overcoming interferon (IFN)-γ resistance ameliorates transforming growth factor (TGF)-β-mediated lung fibroblast-to-myofibroblast transition and bleomycin-induced pulmonary fibrosis.
    Chang CJ, Lin CF, Lee CH, Chuang HC, Shih FC, Wan SW, Tai C, Chen CL.
    Biochem Pharmacol; 2021 Jan 16; 183():114356. PubMed ID: 33285108
    [Abstract] [Full Text] [Related]

  • 13. Sunitinib, a Small-Molecule Kinase Inhibitor, Attenuates Bleomycin-Induced Pulmonary Fibrosis in Mice.
    Huang X, Wang W, Yuan H, Sun J, Li L, Wu X, Luo J, Gu Y.
    Tohoku J Exp Med; 2016 Aug 16; 239(4):251-61. PubMed ID: 27439438
    [Abstract] [Full Text] [Related]

  • 14. Pirfenidone inhibits myofibroblast differentiation and lung fibrosis development during insufficient mitophagy.
    Kurita Y, Araya J, Minagawa S, Hara H, Ichikawa A, Saito N, Kadota T, Tsubouchi K, Sato N, Yoshida M, Kobayashi K, Ito S, Fujita Y, Utsumi H, Yanagisawa H, Hashimoto M, Wakui H, Yoshii Y, Ishikawa T, Numata T, Kaneko Y, Asano H, Yamashita M, Odaka M, Morikawa T, Nakayama K, Kuwano K.
    Respir Res; 2017 Jun 02; 18(1):114. PubMed ID: 28577568
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Regulation of Transforming Growth Factor-β/Smad-mediated Epithelial-Mesenchymal Transition by Celastrol Provides Protection against Bleomycin-induced Pulmonary Fibrosis.
    Divya T, Velavan B, Sudhandiran G.
    Basic Clin Pharmacol Toxicol; 2018 Aug 02; 123(2):122-129. PubMed ID: 29394529
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Myricetin ameliorates bleomycin-induced pulmonary fibrosis in mice by inhibiting TGF-β signaling via targeting HSP90β.
    Li X, Yu H, Liang L, Bi Z, Wang Y, Gao S, Wang M, Li H, Miao Y, Deng R, Ma L, Luan J, Li S, Liu M, Lin J, Zhou H, Yang C.
    Biochem Pharmacol; 2020 Aug 02; 178():114097. PubMed ID: 32535102
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 55.